Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amar Gajjar, MD
St. Jude Children's Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lucille Packard Children'S Hospital at Stanford University Medical Center
Palo Alto, California, United States
- Rady Children'S Hospital
San Diego, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Uf Cancer Center at Orlando Health
Orlando, Florida, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 May 2014
- Primary completion
- 1 Sept 2025
- Completion
- 30 Sept 2027
- Last update posted
- 17 Mar 2026
- Registered enrollment
- 125
- Registry id
- NCT02114229
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.